Depression and other Psychiatric effects after Anabolic steroid usage
The widespread public and media attention towards the long-term health effects of anabolic-androgenic steroid (AAS) usage is mostly directed on pro-bodybuilders and pro-athletes. Most AAS users, however, are not elite athletes, like those portrayed in the media, and many are not even competitive athletes at all. This larger but less visible population of ordinary AAS users began to emerge in about 1980. The senior members of this population are now entering middle age; they represent the leading wave of a new type of aging former substance abusers, with specific medical and psychiatric risks.
Over the last ten to fifteen years, sales in the global nutrition and supplements market have seen an unprecedented spike. This has encouraged a number of new players to step into the market with products that promise to be the elixir of youth, health, and vitality. According to the estimates of the Nutrition Business Journal report, the global nutrition and supplements market stood at US$96 billion as of 2012. A year later, it was approximately US$104 billion globally, industry analysts expect the nutrition supplement market to reach $175 Billion globally by 2020
Creatine is a molecular battery. Cells stick energy-providing phosphate groups on to creatine molecules, and pull them off again when they need them. That’s why power athletes can manage longer sets if they take creatine. The human body gets creatine from foods such as fish and meat, but also makes the substance itself from the amino acids arginine and glycine. When producing creatine, the body also uses methyl groups from the S-adenosylmethionine molecule, which as a result change into homocysteine. Seventy percent of the homocysteine in your body is produced as a result of your body manufacturing creatine. A single 5g dose corresponds to the creatine content of 1.1 kg of fresh, uncooked steak.
Anavar was the old U.S. brand name for the oral steroid oxandrolone, is a drug created by Searle Laboratories, now Pfizer Inc, and introduced into the US in 1964. Oxandrolone is a synthetic anabolic steroid derived from dihydrotestosterone (DHT) by substituting the second carbon atom for oxygen. The drug was prescribed to promote muscle regrowth in disorders which cause involuntary weight loss. It had also been shown to be partially successful in treating cases of osteoporosis. Recently, it was approved as a drug in treating alcoholic hepatitis, Turner syndrome, and weight loss caused by HIV. It is also indicated as an offset to protein catabolism caused by long-term administration of corticosteroids. In addition, the drug has shown positive results in treating anemia and hereditary angioedema.